Eric Elenko, Chief of Research and Strategy Officer at PureTech Health (PRTC), Boston, MA — verified investor profile. See sector focus and contact routes.
PureTech Health is dedicated to giving life to science and transforming innovation into value. They have a strong track record of clinical success, outperforming the biopharma industry average. Their R&D engine has generated 29 new therapeutics and therapeutic candidates, taken from inception to U.S. Food and Drug Administration approval. They focus on enhancing on-target efficacy, enabling oral administration, or improving tolerability to unlock new classes of medicine. Their team has overseen R&D of therapeutics supporting more than 15 regulatory approvals.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Eric Elenko · Full investor directory · Investor access · Company funding database